PillRx only · Kit
Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol
Brands: Simliya · Viorele
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.153
Latest avg · Jul 22, 2026
-17%
Since Dec 17, 2025
6
Active US suppliers
43%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
2.2K
Rx · 2026 Q1
126K
Units dispensed
-70%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aurobindo Pharma Limited | unknown | 2 | SUPPLYING |
| Naari Pte Limited | unknown | 1 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
| Apotex Corp. | unknown | 1 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Sep 3, 2025RECALLRecall (Class II): Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg, 3 Bliste…
Failed Impurities/Degradation Specifications — Recalling firm: Glenmark Pharmaceuticals Inc., USA — US Nationwide.